Halozyme Therapeutics Inc. trailing returns
Halozyme Therapeutics Inc.'s 10-year return is +24.7% a year (CAGR) (+809.4% cumulative). How Halozyme Therapeutics Inc. (HALO) has performed over the last day, week, month and year, over 5, 10 and 20 years, and since inception, through October 2, 2026 — cumulative and annualized, with dividends on or off.
Trailing returns by period#
To 2026-10-02. Annualized (CAGR) for windows of a year or more.
| Period | Path | Annualized | Cumulative |
|---|---|---|---|
| 1 day | — | +2.7% | |
| 5 days | — | -3.5% | |
| 1 month | — | +0.2% | |
| YTD | — | +63.2% | |
| 1 year | +53.2% | +53.2% | |
| 5 years | +21.9% | +169.6% | |
| 10 years | +24.7% | +809.4% | |
| 20 years | +20.8% | +4276.9% | |
| Since inception (2004) | +15.5% | +2484.9% |
Growth of HALO
Actual index level (solid); dashed lines are each window's constant-rate path from start to today.
Methodology#
Trailing returns measure from the closest close about N years before the latest close (2026-10-02). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Total return reinvests dividends (from HALO's split- and dividend-adjusted closes); price return excludes them. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Halozyme Therapeutics Inc.'s 10-year return?
- Over the last 10 years, Halozyme Therapeutics Inc. (HALO) returned about +24.7% a year annualized (+809.4% cumulative total return).
- What is Halozyme Therapeutics Inc.'s 20-year annualized return?
- Over the last 20 years, Halozyme Therapeutics Inc. (HALO) compounded at about +20.8% a year (+4276.9% cumulative).
- What is Halozyme Therapeutics Inc.'s return since inception?
- Since 2004, Halozyme Therapeutics Inc. (HALO) has compounded at about +15.5% a year — +2484.9% in total.